Allen Mooney & Barnes Investment Advisors LLC Has $12 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allen Mooney & Barnes Investment Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.7% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 22,911 shares of the healthcare conglomerate's stock after acquiring an additional 1,445 shares during the period. UnitedHealth Group makes up approximately 2.0% of Allen Mooney & Barnes Investment Advisors LLC's holdings, making the stock its 21st largest holding. Allen Mooney & Barnes Investment Advisors LLC's holdings in UnitedHealth Group were worth $12,000,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Capital & Planning LLC raised its position in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after acquiring an additional 79 shares in the last quarter. Brighton Jones LLC grew its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $27,233,000. Revolve Wealth Partners LLC raised its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the period. Finally, Quent Capital LLC increased its position in shares of UnitedHealth Group by 3.4% in the fourth quarter. Quent Capital LLC now owns 4,250 shares of the healthcare conglomerate's stock worth $2,150,000 after acquiring an additional 140 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $5.11 on Friday, hitting $313.39. The stock had a trading volume of 11,370,931 shares, compared to its average volume of 7,175,406. The business's 50 day moving average is $391.47 and its two-hundred day moving average is $476.22. The stock has a market cap of $284.28 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the firm earned $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insider Activity at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on UNH shares. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Mizuho reduced their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. KeyCorp cut their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.